Los Angeles Hematology Oncology Medical Group — Glendale, California

Los Angeles Hematology Oncology Medical Group is a clinical research site located in Glendale, California, United States 91204.

Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.

Los Angeles Hematology Oncology Medical Group has participated in 10 clinical trials with 4 currently active.

Therapeutic areas: Epithelial Ovarian Cancer, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma.

Sponsors: Klus Pharma Inc., Pfizer, Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Los Angeles Hematology Oncology Medical Group?

Los Angeles Hematology Oncology Medical Group has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Los Angeles Hematology Oncology Medical Group conducted?

Los Angeles Hematology Oncology Medical Group has 10 clinical trials on record, with 4 currently active. Their work covers Epithelial Ovarian Cancer, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma.

Is Los Angeles Hematology Oncology Medical Group accredited by Crixeo Health?

Yes — Los Angeles Hematology Oncology Medical Group holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Los Angeles Hematology Oncology Medical Group?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.